American Heart Association
Evaluating Long-Term Outcomes and Real-World Impact of Cardiac Myosin Inhibition in Adults with Symptomatic NYHA Class II-III Obstructive HCM
Heart Theater
Heart Theater I
Nov 17th , 11:15 AM - 12:00 PM
11 : 15 AM
Long-Term and Real-World Outcomes for Cardiac Myosin Inhibition in Adults With Symptomatic NYHA Class II–III Obstructive HCM
Harper Mariko
Final Pr. ID: -
Authors: Harper Mariko
11 : 15 AM
Long-Term and Real-World Outcomes for Cardiac Myosin Inhibition in Adults With Symptomatic NYHA Class II–III Obstructive HCM
Harper Mariko
Final Pr. ID: -
Authors: Harper Mariko